100
Participants
Start Date
October 31, 2025
Primary Completion Date
February 28, 2026
Study Completion Date
August 31, 2027
Odetiglucan
Odetiglucan 4 mg/kg IV every 3 weeks
Mitazalimab
Mitazalimab 0.9 mg/kg IV every 3 weeks
Lustgarten Foundation
OTHER
University of Pennsylvania
OTHER